Methods and organisms for growth-coupled production of 3-hydroxypropionic acid
The invention provides a non-naturally occurring microorganism having one or more gene disruptions, the one or more gene disruptions occurring in genes encoding an enzyme obligatory coupling 3-hydroxypropionic acid production to growth of the microorganism when the gene disruption reduces an activity of the enzyme, whereby the one or more gene disruptions confers stable growth-coupled production of 3-hydroxypropionic acid onto the non naturally occurring microorganism. The disruptions can be complete gene disruptions and the non-naturally occurring organisms can include a variety of prokaryotic or eukaryotic microorganisms. A method of producing a non-naturally occurring microorganism having stable growth-coupled production of 3-hydroxypropionic acid is further provided. The method includes: (a) identifying in silico a set of metabolic modifications requiring 3-hydroxypropionic acid production during exponential growth, and (b) genetically modifying a microorganism to contain the set of metabolic modifications requiring 3-hydroxypropionic acid production.
1. An isolated non-naturally occurring microorganism comprising a set of gene disruptions coupling 3-hydroxypropionic acid production to growth of said microorganism, wherein said microorganism utilizes an anaerobic β-alanine 3-HP precursor pathway and said set of gene disruptions comprise a disruption of one or more pflAB genes and a disruption of a ldhA gene, wherein said microorganism comprises stable growth-coupled production of 3-hydroxypropionic acid.
2. The isolated non-naturally occurring microorganism of claim 1 , wherein said set of gene disruptions further comprise a disruption of one or more aceEF genes, a disruption of one or more ptsG genes or a disruption of one or more frdABCD genes.
3. The isolated non-naturally occurring microorganism of claim 1 , wherein said disruption of one or more genes comprises a deletion.
4. The isolated non-naturally occurring microorganism of claim 1 , wherein said microorganism comprises a bacterium, yeast or fungus.
5. The isolated non-naturally occurring microorganism of claim 4 , wherein said bacteria comprises a species selected from E. coli, A. succiniciproducens, A. succinogenes, M succiniciproducens, R. etli, Bacillus subtilis, Corynebacterium glutamicum, Gluconobacter oxydans, Zymomonas mobilis, Lactococcus lactis, Lactobacillus plantarum, Streptomyces coelicolor, Clostridium acetobutylicum, Pseudomonas fluorescens, Klebsiella oxytoca , and Pseudomonas putida.
6. The isolated non-naturally occurring microorganism of claim 4 , wherein said yeast comprises a species selected from Saccharomyces cerevisiae, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces marxianus, Penicilium chrysogenum, Aspergillus terreus, Aspergillus niger , and Pichia pastoris.
7. The isolated non-naturally occurring microorganism of claim 2 , wherein said set of gene disruptions comprise a disruption of one or more pflAB genes, a disruption of a ldhA gene and a disruption of one or more aceEF genes.
8. The isolated non-naturally occurring microorganism of claim 2 , wherein said set of gene disruptions comprise a disruption of one or more pflAB genes, a disruption of a ldhA gene, a disruption of one or more aceEF genes and a disruption of one or more ptsG gene.
9. The isolated non-naturally occurring microorganism of claim 2 , wherein said set of gene disruptions comprise a disruption of one or more pflAB genes, a disruption of a ldhA gene, a disruption of one or more aceEF genes and a disruption of one or more frdABCD genes.
10. The isolated non-naturally occurring microorganism of claim 2 , wherein said set of gene disruptions comprise a disruption of one or more pflAB genes, a disruption of a ldhA gene, a disruption of one or more aceEF genes, a disruption of one or more ptsG genes and a disruption of one or more frdABCD genes.